










Izaak Walton Killam Health Centre, Dalhousie University, Halifax, NS,
Canada
Liverpool School of Tropical Medicine, Liverpool, UK
Correspondence
Heather Scott, Department of Obstetrics and Gynaecology, IWK Health Centre, Halifax, NS, Canada.
Email: heather.scott@iwk.nshealth.ca
Received: 21 November 2019 | Accepted: 01 December 2019
Despite worldwide efforts to reduce maternal mortality, the WHO estimates that in 2017,
810 women died every day, with over two‐thirds of these deaths mainly from preventable
causes related to pregnancy and childbirth.[ 1 ] It was estimated that over 90% of these
deaths occurred in low‐resource settings, although women are still dying from preventable
causes in high resource countries as well. Efforts continue globally to ensure that all
maternal deaths are counted and reviewed for preventable causes and antecedent factors,
and that appropriate recommendations are made and implemented in order to prevent
further deaths. Maternal death surveillance and response (MDSR) remains the cornerstone
of quality improvement activities related to improving maternal outcomes. Increasingly,
these activities are also being linked to serious maternal complications as well as perinatal
morbidity and mortality.
In this issue of Paediatric and Perinatal Epidemiology, Jayakody and Knight[ 2 ] seek to
understand more fully how recommendations to reduce maternal deaths are implemented
and acknowledge that the critical “Response” portion of MDSR is often poorly developed.
They undertook a scoping review of English language publications focusing specifically on
the response to recommendations following confidential enquiries into maternal deaths
(CEMD), a form of MDSR. They concluded that overall, the response component was
inadequate with substantial gaps between recommendations and implementation.
Furthermore, there was a lack of accountability leading to reduced effectiveness of MDSR.
Engaging key partners, ensuring that there are appropriate indicators to monitor outcomes,
and advocacy were fundamental to success. The question of course is “why is response
inadequate?”
The inability to respond to identified gaps depends on the number of maternal deaths and
the nature and timeliness of the review process. Many countries have opted for confidential
enquires in order to both count and review maternal deaths. While confidential enquiries
are viewed as the “gold standard” for maternal death review, many low‐ and middle‐income
countries (LMICs) still struggle to ensure adequate facility‐level reviews owing to lack of
adequate resources. Fewer deaths in high‐income settings make individual, confidential







and some European countries still struggle to report maternal deaths accurately and to
implement appropriate recommendations. While the “gold standard” may be a confidential
enquiry, recommendations from confidential enquiries are often made and potentially
implemented years after the maternal death. Local, facility‐level reviews might in fact lead to
more timely and effective recommendations and actions. In addition, advocates for
maternal mortality review argue that any process developed for maternal mortality should
also be used to assess the more widespread problem of serious maternal morbidity. The
causes of and factors leading to serious maternal morbidity are often similar to causes of
mortality: reviews of these “near misses” can help to identify and address modifiable
conditions.
While causes of death often differ between low‐ and high‐income countries, response to
recommendations may be as challenging as in LMICs. Access to care is frequently identified
as a contributing factor and is an issue around the globe. Remote communities in northern
Canada, for example, may have limited access to timely and appropriate care (REF).
Universal health coverage (UHC) is critical and remains a priority worldwide for those
seeking to achieve equitable health care. Advocacy for UHC has been a high‐level response
to maternal mortality. Countries such as Afghanistan, Mexico, Rwanda and Thailand have
shown that UHC is a powerful force to improve the wellbeing of traditionally marginalised
populations, specifically women and girls.[ 3 ] Some high‐income countries, such as the
United States, still lack truly universal health coverage ensuring that access to safe,
appropriate and equitable care remains a factor in many maternal deaths.[ 4 ]
In LMICs, maternal deaths are usually related to haemorrhage, severe hypertension or
sepsis with numerous factors impacting the care women receive and why it may be
suboptimal.[ 5 ] Recommendations are often directed at education, training and resource
allocation. High‐income countries are increasingly struggling to understand the factors that
drive maternal morbidity and mortality, including obesity and its related medical, surgical
and anaesthetic risks. Opioid use is a growing factor.[ 6 ] New immigrants pose a range of
challenges with language barriers, poorly understood cultural differences and unrecognised
diseases that are common in their home country but uncommon in their adopted country. It
is clear therefore that appropriate responses to recommendations are not homogeneous
given the heterogeneity of causes of maternal death.
Regardless of the setting, capturing accurate data is difficult. Vital statistics remains a
critical component of maternal death surveillance. The World Bank and the WHO have
developed a Global Civil Registration and Vital Statistic Scaling Up Investment Plan[ 7 ]
covering the period from 2015 to 2024. Millions of people are denied appropriate services,
including health coverage, when births and deaths are not recorded. Without accurate vital
statistical information, improvements in care, or lack thereof, cannot be monitored.
Rich and informative data collected from confidential enquires do help to guide
recommendations and policy development. High‐income countries such as the UK, the
Netherlands, Japan, France and the Nordic countries have comprehensive review processes.
In addition, South Africa, Malaysia, India, Kenya and Malawi, amongst others, also have
developed confidential review processes. Jayakody and Knight[ 2 ] focus on a lack of
accountability, the need for dissemination tools and implementation guides, and the
importance of engaging key decision‐makers. Systems that include comprehensive review
and reporting create a voice to speak to decision‐makers, thereby creating a means of
implementing recommendations. Even so, the “response” of MDSR is clearly problematic.
What can be done to improve this critical component, particularly in countries where a well‐




While confidential enquiries are ideal, and evidence points to their effectiveness,
alternatives in resource‐poor settings should be investigated. Countries and regions should
be encouraged to start with well‐developed local facility reviews with clear
recommendations and implementation guidelines, gradually building to a more
comprehensive national system. Confidentiality may be difficult to ensure but the principles
of no blame or shame and the need to identify system‐related factors rather than individual
caregiver‐related factors remain. Before embarking on any review process, objectives should
be clearly stated and appropriate indicators identified. In addition, ability to collect
information relating to those indicators should be confirmed in advance. Too often
initiatives are implemented without determining how—or whether—progress will be
monitored.
Work is ongoing to improve maternal wellbeing, regardless of the setting and resources
available. The third Sustainable Development Goal is to promote healthy lives and promote
wellbeing for all, at all ages with the goal to reduce the global maternal mortality ratio to
<70 per 100 000 livebirths by 2030, with the maternal mortality ratio being no greater than
twice the current ratio.[ 8 ] Reduction in substance use, universal access to sexual and
reproductive health services, avoiding unsafe abortion practices, and achieving universal
health coverage are all goals encompassed by the goal to promote healthy lives for all and
are appropriate high‐level responses to maternal mortality.
All countries should strive to develop robust systems to collect and review information about
maternal deaths and severe maternal morbidity. Once in place, developing systems of
response that are effective and manageable should be a priority that is addressed early
rather than late in the process. Appropriate, measurable and actionable indicators need to
be identified. Accountability to key stake holders, in particular women and their families,
remains paramount. While every maternal death is a tragedy, not learning lessons and
acting on the lessons learnt is a greater disservice.
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